Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific, AnaSpec, Protein Discovery

Premium
Thermo Fisher Scientific this week launched the MSQ Plus single quadrupole LC/MS detection system. The system has been enhanced to feature fully automated system security, secure data integrity, built-in audit trails, and electronic signatures and sign-offs, the company said in a statement. The MSQ Plus can be “seamlessly” integrated with Thermo Fisher’s Accela HPLC.
 
Thermo Fisher also introduced its Sorvall Legend Microcentrifuge Series this week. The instruments have higher speeds, higher acceleration rates, increased capacity, and improved safety and convenience, the company said in a statement.
 

 
AnaSpec this week introduced its SOCS, or suppressor of cytokine signaling, antibodies. According to the company, the proteins “form part of a classical negative feedback loop that regulates cytokine signal transduction via a STAT-induced transcriptional mechanism.” The SOCS antibodies, validated in western blots using cell or tissue lysates, come in 50 µg format.
 
AnaSpec also launched its EnzoLyte 520 Renin Assay Kit last week. The company says its kit is 40 times more sensitive than comparable kits on the market. While other kits offer sub-nanomolar potency and selectivity, AnaSpec says its product offers picomolar sensitivity.
 

 
Protein Discovery last week launched its Tissue Imaging-by-the-Slice service that reads and delivers tissue imaging MALDI-MS data for $1,200. The data comes from tissue samples supplied by customers.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.